Tests with the products showed that drying and making of tablets did not affect the ability of the vaccines to protect mice or elicit antibodies in rabbits.
MNIany vaccines now in use are available only in liquid form. Since these fluid preparations usually have a limited shelf-life, even under optimal conditions of storage, their production and distribution in final containers is generally based on projected needs over a relatively short period of time. From the point of view of stockpiling essential immunizing agents in the event of a national emergency, fluid vaccines are incompatible because of their short shelf-life and the large amount of space required to transport and house material diluted ready for use. On the other hand, a vaccine capable of being converted to the dry form in all probability would be more stable in this form, even under adverse storage conditions, and this would therefore be the logical form in which a stockpile should be held. However, dispensing of dried material into glass containers the same size as required for diluted fluid vaccine does not alleviate the storage problem On the other hand, preparation of dried products compressed into multidose tablets would permit storage of many multidose units in one container, thus conserving storage space. The reconstituting fluid and containers required are much less critical and can be obtained from many sources when needed.
A study was undertaken in this laboratory to determine the feasibility of tableting a commonly used standard bacterial vaccine. Typhoid vaccine was employed as the model in this study, and the effect of converting into tablet form the heat-killed phenolized fluid vaccine (Holt and Hitchens, 1937) and the acetone-killed and dried vaccine (Landy, 1953) , both prepared from the same harvest of typhoid cells, was determined.
MIATERIALS AND MIETHODS
Salmonella typhosa strain Ty2 (Felix), obtained from the culture collection of the Walter Reed Army Institute of Research, was employed for the production of the typhoid vaccines used in this study. Heat-inactivated, phenolized monovalent vaccine was prepared from part of the S. typhosa harvest by the method described by Holt and Hitchens (1937) , with the exception that heat inactivation and addition of phenol were carried out on the harvested material without prior dilution. Part of the heatinactivated phenolized product was dried from the frozen state in bulk in a chamber dryer. The acetone-killed and dried vaccine was prepared from another portion of the same harvest by the method of Landy (1953) .
Sufficient quantities of dried bacterial bulk were compounded with the required amount of dried sterile NaCl (Landy, 1953) to yield, on rehydration, 50 ml of a suspension equivalent to the diluted fluid vaccine which contained 109 organisms per ml in physiological saline. Weighed amounts of the bacteria-salt powder were placed in 50-ml vaccine bottles and sealed under vacuum. Additional weighted samples were compressed into tablets by Lewis Miner, Pharmacy Department, Walter Reed General Hospital, with a hand-operated Stokes singlepunch tableting machine (F. J. Stokes Machine Co., Philadelphia, Pa.) using light to moderate pressure. The parts of the tableting machine in contact with the dried material were disinfected by spraying with ether. The tablets were also placed in individual 50-ml vaccine bottles and sealed under vacuum.
Biological assays. Mlouse-protective potency tests were performed using the active-immunization technique described by Landy (1952) . Determinations of the antigenicity of the vaccines were made by the immunization of three rabbits, each with three doses (0.5 ml subcutaneous, 0.5 ml intravenous, and 1.0 ml intravenous) at 4-day intervals. The rabbits were bled on the seventh day after the last dose, and the sera were tested for H, 0, and Vi agglutinins. Chemical assay. The nitrogen content of the vaccines was determined by the micro-Kjeldahl technique, followed by nesslerization. RESULTS When 50 ml of distilled water were added to the bottle containing one tablet and this was shaken for 3 to 5 min, a homogeneous suspension resulted. Sterility tests on the reconstituted vaccine showed no bacterial contamination. Consistency of the tableting operation was evidenced by the weights of successive tablets and the nitrogen content of the reconstituted vaccine (Table 1) . 
TABLETS OF BACTERIAL VACCINE FOR PARENTERAL USE
The results of the mouse-protection tests (Table 2) show that freeze-drying of the heat-inactivated phenolized vaccine, or compressing of the dried heat-phenol and acetone-treated products, had no significant effect on the protective potencies of the vaccines against a challenge suspended in 5 % hog gastric mucin. In several instances, the mouse-potency results of the tablet appeared to be greater than that of the powder from which the tablet was made. However, because of the wide confidence limits, these differences are not significant. Similarly, the treatments had no appreciable effect on the ability of the vaccines to elicit H, 0, and Vi antibodies in rabbits (Table 2) .
Samples of the dried, tableted vaccines were stored in vacuo at 4 C for 18 months, and were then used to immunize mice and rabbits to assess the stability of the compressed vaccine. The results of the tests for immunogenicity and antigenicity on the aged tableted vaccines (Table 3) were essentially the same as those originally obtained and reported in Table 2 .
DISCUSSION
The results of the present study demonstrate that the sterile tableting of a bacterial vaccine can be successfully accomplished on a laboratory scale. That the relatively small amount of antigen can be uniformly distributed throughout the inert filler, originally shown by Landy (1953) , is indicated by the consistent results of nitrogen determinations on individual tablets. Further evidence of uniformity of the product is provided by the insignificant variations in the weights of the individual tablets. Miaintenance of antigenicity of the two types of vaccine through the freeze-drying and tableting processes is shown by the results of the animal assays. Furthermore, no loss in the mouse protective potency and in the H, 0, and Vi antigenicity is observed after storage of the tableted vaccines at 4 C for 18 months, indicating that compression or intimate contact with the NaCl filler had no effect on the stability of these antigens. The demonstrated stability of the H, 0, and Vi antigens may reflect the stability of all immunizing elements of the vaccines.
As has already been pointed out, vaccines in dried form generally have an extended shelf-life as compared with fluid products. Compressing the stable, dry vaccine into tablet form would, in our opinion, add these advantages. (i) Tablets can be readily prepared in a variety of sizes contain3:ng any specified number of doses. (ii Standard vaccine 0/10 5/10 10/10 10/10 0.00011
±I10.00006
It is felt, however, that preparing vaccines for parenteral use in multidose tablet form presents an approach to stockpiling essential immunizing agents in a minimal amount of storage space that is worth further consideration. The present study has demonstrated that the preparation of typhoid vaccine in multidose tablets is feasible. It is possible that other immunizing agents may also be successfully converted to this form.
